Watch Ticker

Eledon Pharmaceuticals, Inc. Common Stock

Go to Eledon Pharmaceuticals, Inc. Common Stock Website

$3.10

-0.03 (-0.96%)

Live

Previous Close

$3.44

Day Range

$3.1905 - $3.51

Previous Day Range

$3.12 - $3.3

Market Cap

$187.4 million USD

Day Vol.

2.0 million

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patient...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Global Renal Transplant Therapeutics Market is Expected to Cross ~USD 18 Billion by 2032 | DelveInsight

The global renal transplant therapeutics market is projected to grow significantly by 2032, driven by increasing kidney disease prevalence, advanced research, and innovative therapies to prevent transplant rejection.

Related tickers: NVS, ELDN, BIIB.

Read Full Article

N/A - Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals announced that its investigational anti-CD40L antibody, tegoprubart, was used as a key component of the immunosuppression therapy regimen in a patient who recently received a transplanted kidney from a genetically modified pig. The procedure was performed at Massachusetts General Hospital in collaboration with partner eGenesis.

Related tickers: ELDN.

Read Full Article

Trending Tickers

Please sign in to view